Join
Live feed
·
PRReleasevia Quantisnow
Akari Therapeutics plc logo

Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers

ByQuantisnow·Wall Street's wire, on your screen.
AKTX· Akari Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTX (Akari Therapeutics plc) and more on Quantisnow.